Ovid Therapeutics Inc. Collaboration Agreements
3 Contracts & Agreements
- Collaboration and License Agreement, by and between the Company and Angelini Pharma Rare Diseases AG, dated July 9, 2020 (Filed With SEC on March 15, 2021)
- Collaboration and License Agreement, by and between the Company and Angelini Pharma Rare Diseases AG, dated July 9, 2020 (Filed With SEC on November 13, 2020)
- LICENSE AND COLLABORATION AGREEMENT BY AND BETWEEN TAKEDAPHARMACEUTICAL COMPANY LIMITED AND OVID THERAPEUTICS INC. JANUARY 6, 2017 Table of Contents (Filed With SEC on April 10, 2017)
